QI
CADX

Quotient Investors’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Quotient Investors’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,900
Closed -$99K – 291
2013
Q4 		$99K Hold
10,900
– – 0.02% 239
2013
Q3 		$69K Buy
+10,900
New +$69.3K 0.02% 244

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Quotient Investors's CADX Position: Q1 2014 in Review

Quotient Investors sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 10,900 shares — an estimated $99K sold.

Quotient Investors first reported a position in CADX in Q3 2013 and held it in 2 quarters. The position peaked at $99K in Q4 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Quotient Investors reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Quotient Investors sold 10,900 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $99K.
  • Quotient Investors first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q3 2013 and held it in 2 quarters.
  • Quotient Investors's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $99K in Q4 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Quotient Investors's 13F filing for Q1 2014, filed 4 Apr 2014.